skitahoe,
Exactly!; ). The shorts and MMs are getting help from those who are selling some of their shares while we wait on Flaskworks. Once approval hits with resulting broad media coverage that Flaskworks is nearing completion in the next year or so, folks will start investing on a regular basis in anticipation of partnership or buyout value. As much talk as there is about holding the price down after approval, the idea that this is a platform technology for all solid tumor cancers will grow like a wildfire and the market makers and others will not be able to contain that understanding especially once Advent is talking about their plans with Flaskworks. The leadership there has not been tainted in the eyes of investors like has happened with NWBO because of all the delays created by lack of funding in no small part due to manipulation, inexperience and waiting out mature data sets.
In the mean time, NWBO management can see what is happening and knows what they are dealing with as share value decreases the borrowing power of those remaining to be sold. Best wishes.
Market Data 
Markets 
AI
